Eduardo Fuentes Selected Research

Eduardo Fuentes Research Topics

Disease

18	Thrombosis (Thrombus) 04/2021 - 01/2012
7	Cardiovascular Diseases (Cardiovascular Disease) 05/2021 - 01/2013
6	Inflammation (Inflammations) 06/2022 - 01/2013
4	Frailty 06/2022 - 01/2020
3	Hemorrhage 01/2022 - 08/2014
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2020 - 10/2018
2	Neoplasms (Cancer) 04/2022 - 12/2016
2	Chronic Disease (Chronic Diseases) 05/2021 - 01/2020
2	Obesity 01/2020 - 01/2013
2	Hypertension (High Blood Pressure) 01/2020 - 12/2013
2	Atherosclerosis 01/2015 - 07/2013
1	Kidney Diseases (Kidney Disease) 07/2021
1	Astrocytoma (Pilocytic Astrocytoma) 11/2020
1	Cognitive Dysfunction 01/2020
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Myocardial Infarction 11/2019
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2019
1	Hyperglycemia 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019
1	Myocardial Ischemia (Ischemic Heart Diseases) 12/2017
1	Hypoxia (Hypoxemia) 12/2016
1	Vascular Diseases (Vascular Disease) 01/2016
1	Insulin Resistance 12/2013
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2013
1	Abdominal Obesity 12/2013
1	Dyslipidemias (Dyslipidemia) 12/2013
1	Metabolic Diseases (Metabolic Disease) 12/2013

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2013
4	Adenosine (Adenocard)FDA LinkGeneric 12/2016 - 01/2012
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2013
3	NucleosidesIBA 12/2017 - 01/2013
2	Adenosine Triphosphate (ATP)IBA 11/2020 - 12/2015
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020 - 01/2013
2	MicroRNAs (MicroRNA)IBA 01/2019 - 07/2015
2	Pharmaceutical PreparationsIBA 01/2018 - 01/2013
2	GuanosineIBA 12/2017 - 07/2013
2	LigandsIBA 10/2017 - 12/2013
2	Transcription Factors (Transcription Factor)IBA 10/2017 - 01/2013
2	AdipokinesIBA 12/2013 - 01/2013
1	AntioxidantsIBA 06/2022
1	PhytochemicalsIBA 04/2022
1	PhosphatidylserinesIBA 01/2022
1	triphenylphosphoniumIBA 01/2022
1	PotassiumIBA 07/2021
1	Advanced Glycation End ProductsIBA 05/2021
1	3-methylquercetinIBA 04/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2021
1	CalciumIBA 11/2020
1	Purinergic P2X1 ReceptorsIBA 11/2020
1	Ion Channels (Ion Channel)IBA 11/2020
1	A-factor (Streptomyces)IBA 01/2020
1	Growth Differentiation Factor 15IBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	AcidsIBA 01/2020
1	8-epi-prostaglandin F2alphaIBA 01/2020
1	Thromboxane B2IBA 01/2020
1	lawsoneIBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2019
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 11/2019
1	Thrombin FDA Link 01/2019
1	CollagenIBA 01/2019
1	AntibodiesIBA 01/2019
1	hydroquinone (Esoterica)FDA Link 10/2018
1	NADPH Oxidase 2IBA 10/2018
1	Protein Isoforms (Isoforms)IBA 10/2018
1	quinone (benzoquinone)IBA 10/2018
1	NADPH Oxidases (NAD(P)H oxidase)IBA 10/2018
1	Biological ProductsIBA 12/2017
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2017
1	PolyphenolsIBA 05/2017
1	CoagulantsIBA 01/2017
1	Adenosine A2B ReceptorIBA 12/2016
1	Adenine NucleotidesIBA 12/2015
1	Adenosine Diphosphate (ADP)IBA 12/2015
1	Blood Coagulation Factors (Coagulation Factor)IBA 09/2015
1	Hemostatics (Antihemorrhagics)IBA 09/2015
1	AnticoagulantsIBA 09/2015
1	Chemokine CCL5IBA 01/2015
1	SelectinsIBA 01/2015
1	fluorexon (calcein)IBA 07/2014
1	Rose BengalIBA 07/2014
1	EstersIBA 07/2014
1	Inosine FDA Link 01/2014
1	Chlorogenic AcidIBA 01/2014
1	PPAR gammaIBA 12/2013
1	Sirtuin 1IBA 12/2013
1	FlavonoidsIBA 01/2013
1	LipidsIBA 01/2013

Therapy/Procedure

5	Therapeutics 11/2019 - 01/2013
1	Polypharmacy 01/2020
1	Mediterranean Diet 11/2019
1	Lasers (Laser) 07/2014